Global Health News and Research

RSS

Post-traumatic stress disorder common among refugees in western countries

Refugees settled in western countries could be about ten times more likely to have posttraumatic stress disorder than general populations in those countries, suggests a study published in this week’s issue of The Lancet.

7 Apr 2005

Integrating HIV prevention and care in Africa

On April 15, 2005 the UCLA AIDS Institute will host a full day symposium on AIDS in Africa entitled Integrating HIV Prevention and Care in Africa: Existing Challenges and Innovative Solutions.

6 Apr 2005

Tarvacin shows significant anti-viral activity

Peregrine Pharmaceuticals today announced that there will be two presentations, April 4 and 6, at the American Association of Immunologists (AAI) annual meeting in San Diego, California, indicating the anti-viral potential of its Tarvacin antibody. Dr. Melina Soares of The University of Texas Southwestern Medical Center at Dallas will present pre-clinical data titled "Targeting inside-out phospholipids on viruses in a guinea pig model of Lassa fever."

4 Apr 2005

Inexpensive treatment stops multi-drug resistant TB in its tracks

A standard and inexpensive tuberculosis treatment regimen cut the overall TB rate in half and lowered the rate of drug-resistant cases even more dramatically in a remote Mexican health district with a high prevalence of the disease.

3 Apr 2005

Could NAADP/cholecystokinin-combo attack fat from inside and out?

One traditional approach to pharmaceutical design uses so-called “first messengers” – hormones, other natural facilitators or synthetic products – to initiate various cellular cascades for the desired physiological effect. To date, despite concerted efforts at all levels of research, this approach has failed to develop a truly successful obesity drug to address this major global health problem.

3 Apr 2005

Protecting children from industrial chemicals in the environment

American children are likely to face serious health consequences from new and existing industrial chemicals in the environment, argue a group of researchers in a report in this month's premier open-access global health journal PLoS Medicine.

29 Mar 2005

Marker for new blood vessel formation in tumors

In a paper in this month's freely-available online global health journal PLoS Medicine, Roland Haubner and colleagues describe how a compound they have developed can be used together with highly sensitive positron emission tomography (PET) scanning to measure the amount of new blood vessel growth in some tumors.

29 Mar 2005

Vaccine prevents deadly pneumonia in African children

Global health leaders today presented new research showing that vaccinating infants against Streptococcus pneumoniae -- a bacterium that causes deadly pneumonia, meningitis and sepsis -- could substantially reduce death and serious illness among children in the developing world. If used widely, a pneumococcal conjugate vaccine could prevent hundreds of thousands of child deaths each year.

28 Mar 2005

Availability of cheap HIV-AIDS drugs threatened by Indian patent law

A controversial Indian patents bill could threaten the lives of millions of people worldwide living with HIV-AIDS and cancer by banning companies from producing cheap copies of brand name drugs.

21 Mar 2005

3 million newborn babies' lives could be saved for less than $1 per child

3 million newborn babies' lives could be saved for less than $1 per child, with interventions such as tetanus immunization during pregnancy, exclusive breastfeeding, clean delivery and antibiotics to treat illness.

4 Mar 2005

Prospects for a safe, effective AIDS vaccine are improving

Prospects for a safe, effective AIDS vaccine are improving as researchers from the public and private sectors begin to collaborate in new and creative ways, researchers said recently at the 2005 Annual Meeting of the American Association for the Advancement of Science (AAAS).

22 Feb 2005

Open source biotechnology from Australia

In a publication in the scientific journal, Nature, a team at CAMBIA in Canberra unveils the 'kernel' of the world's first 'explicit open source' biotechnology toolkit.

13 Feb 2005

Basis for deciding cost effectiveness of TB vaccination programmes questioned

Current risk assessment methods, which are used to inform the timing and extent of tuberculosis (TB) vaccination programmes, may overestimate the real risk of contracting the disease up to threefold, reveals research in Thorax.

26 Jan 2005

Health initiatives have led to Arab and Israeli cooperation in the Middle East

The cross-border project led to Palestinian and Israeli basic science research programmes between Bethlehem University and Tel Aviv University in the genetics of hearing loss, and generated joint-publications. From this followed a project to screen and habilitate 17 000 Israeli, Jordanian and Palestinian newborns for hearing loss.

26 Jan 2005

Novel treatment promises to be an effective cure for tuberculosis

Researchers in Belgium have uncovered a novel treatment that promises to be an effective cure for tuberculosis (TB). The respiratory disease has been experiencing a major global comeback due to the emergence of resistant strains of the bacteria that causes it and the spread of AIDS.

9 Jan 2005

Scientists have identified a novel anti-tuberculosis (TB) compound

Scientists at Johnson & Johnson Pharmaceutical Research and Development have identified a novel anti-tuberculosis (TB) compound that works better and faster than the current standard of care in mouse models of TB infection.

14 Dec 2004

Start today of human tests for a preventive vaccine against the respiratory disease SARS

Powerful research tools that speed up vaccine development have led to the start today of human tests for a preventive vaccine against the respiratory disease SARS. The disease killed hundreds of people around the world before it was brought under control in 2003 with aggressive conventional public health measures.

13 Dec 2004

Britain pledges four million doses of smallpox vaccine to a new global stockpile

Britain's Health Secretary John Reid today pledged to contribute four million doses of smallpox vaccine to a new global stockpile being assembled by the World Health Organisation.

13 Dec 2004

A decade of neglect has weakened UNICEF and threatened the future of child survival

As a high-level forum assessing the progress on global health in relation to the millennium development goals concluded in Abuja, Nigeria, last week, the rhetoric of success repeated by those charged with ending the needless deaths of millions of the world's children masks their own deep-seated failure to grapple with critical institutional weaknesses in their own ranks.

13 Dec 2004

New technologies boost immunisation rates, safety

As global health leaders struggle to meet the United Nations goal of reducing mortality among the world's poorest children, vaccines are attracting more and more attention. The purchase of the vaccine is just the beginning, however, as the effectiveness of a vaccine is only as good as its delivery system.

6 Dec 2004